Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com

GILEAD SCIENCES, INC.

Statements

Exhibits

d10k.htmdex23.htmdex107.htmdex108.htmdex1090.htmdex211.htmdex231.htmdex311.htmdex312.htmdex321.htmgild-20101231.xmlR19.xmlR44.xmlR80.xmlR97.xmlR35.xmlR51.xmlR29.xmlR11.xmlR10.xmlR60.xmlR30.xmlR100.xmlR54.xmlR8.xmlR36.xmlR41.xmlR79.xmlR66.xmlR72.xmlR58.xmlR22.xmlR89.xmlR74.xmlR31.xmlR45.xmlR43.xmlR73.xmlR49.xmlR53.xmlR92.xmlR18.xmlR86.xmlR98.xmlR94.xmlR32.xmlR82.xmlR67.xmlR57.xmlR12.xmlR3.xmlR14.xmlR90.xmlR48.xmlR78.xmlR15.xmlR24.xmlR69.xmlR20.xmlR4.xmlR83.xmlR77.xmlR27.xmlR101.xmlR39.xmlR75.xmlR81.xmlR96.xmlR68.xmlR70.xmlR50.xmlR33.xmlR16.xmlR28.xmlR102.xmlR76.xmlR52.xmlR62.xmlR9.xmlR6.xmlR61.xmlR88.xmlR91.xmlR85.xmlR5.xmlR23.xmldefnref.xmlR95.xmlR84.xmlR46.xmlR21.xmlR99.xmlR87.xmlR13.xmlR34.xmlR26.xmlR93.xmlR59.xmlR64.xmlR1.xmlR2.xmlR103.xmlR37.xmlR63.xmlR56.xmlFinancial_Report.xlsR55.xmlR47.xmlR38.xmlR25.xmlR7.xmlR65.xmlR40.xmlR71.xmlR42.xmlR17.xml

Graphics

g121379g49a70.jpg
NotesSupport
aboutterms
2.2.0.25truefalse40601 - Disclosure - Restructuring (Narrative) (Details)truefalseIn Millionsfalse1falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Selling, General and Administrative Expenses [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010252http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseSelling, General and Administrative Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_SellingGeneralAndAdministrativeExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Selling, General and Administrative Expenses [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200935http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseSelling, General and Administrative Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_SellingGeneralAndAdministrativeExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.gilead.com/taxonomy/role/disclosurerestructuringnarrativedetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse1falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Selling, General and Administrative Expenses [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010252http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseSelling, General and Administrative Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_SellingGeneralAndAdministrativeExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Selling, General and Administrative Expenses [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200935http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseSelling, General and Administrative Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_SellingGeneralAndAdministrativeExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse2false0us-gaap_RestructuringAndRelatedCostCostIncurredToDateus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse1060000010.6falsetruefalsefalsefalse2truefalsefalse2620000026.2falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of costs incurred to date for the specified type of restructuring cost.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 falsefalse3false0gild_TotalAmountToBeIncurredInConnectionWithOurRestructuringPlangildfalsedebitdurationTotal Amount To Be Incurred In Connection With Our Restructuring Planfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3680000036.8falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal Amount To Be Incurred In Connection With Our Restructuring PlanNo authoritative reference available.falsefalse4false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.gilead.com/taxonomy/role/disclosurerestructuringnarrativedetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Research Development Expenses [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010242http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseResearch Development Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_ResearchDevelopmentExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : CVT/Cardiovascular Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Research Development Expenses [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200934http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseCVT/Cardiovascular Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_CvtCardiovascularRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseResearch Development Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_ResearchDevelopmentExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse5false0us-gaap_RestructuringAndRelatedCostCostIncurredToDateus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse34000003.4falsefalsefalsefalsefalse2truefalsefalse2570000025.7falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of costs incurred to date for the specified type of restructuring cost.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 falsefalse6false0gild_TotalAmountToBeIncurredInConnectionWithOurRestructuringPlangildfalsedebitdurationTotal Amount To Be Incurred In Connection With Our Restructuring Planfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2910000029.1falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal Amount To Be Incurred In Connection With Our Restructuring PlanNo authoritative reference available.falsefalse7false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.gilead.com/taxonomy/role/disclosurerestructuringnarrativedetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse5falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : Durham Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Selling, General and Administrative Expenses [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201023212http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseDurham Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_DurhamRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseSelling, General and Administrative Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_SellingGeneralAndAdministrativeExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse8false0us-gaap_RestructuringAndRelatedCostCostIncurredToDateus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse1460000014.6falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of costs incurred to date for the specified type of restructuring cost.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 falsefalse9false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.gilead.com/taxonomy/role/disclosurerestructuringnarrativedetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse6falsefalseUSDtruefalse{us-gaap_StatementScenarioAxis} : Durham Restructuring [Member] {us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxis} : Research Development Expenses [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201023211http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseDurham Restructuring [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldigild_DurhamRestructuringMemberus-gaap_StatementScenarioAxisexplicitMemberfalsefalseResearch Development Expenses [Member]us-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisxbrldihttp://xbrl.org/2006/xbrldigild_ResearchDevelopmentExpensesMemberus-gaap_RestructuringAndRelatedCostByTypeOfRestructuringAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse10false0us-gaap_RestructuringAndRelatedCostCostIncurredToDateus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse1040000010.4falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of costs incurred to date for the specified type of restructuring cost.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 146 -Paragraph 20 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 95-3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 falsefalse210Restructuring (Narrative) (Details) (USD $)HundredThousandsUnKnownUnKnownUnKnownfalsetrue